Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial
暂无分享,去创建一个
M. Mauro | A. Hochhaus | D. Réa | Y. Minami | D. D’Alessio | R. Lawrance | V. Maheshwari | Š. Narbutas | Ying Wu | C. Boquimpani | G. Sharf | A. Allepuz